Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

Cited by (187)

Items 101–187 of 187

1. Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
   Ana Sofía Vallés, Francisco José Barrantes · 2023 · Cells
2. Targeting Nicotinic Receptors for Parkinson's Disease Therapy
   Maryka Quik, Tanuja Bordia, Luping Z. Huang, Xiomara A. Perez · 2011 · CNS & Neurological Disorders - Drug Targets
3. Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice
   Mikihiko Arikawa, Yoshihiko Kakinuma, Takemi Handa, Fumiyasu Yamasaki, Takayuki Sato · 2011 · PLoS ONE
4. Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
   Sudhakar Subramaniam, Iddo Magen, Nicholas Bove, Chunni Zhu, Vincent Lemesre, Garima Dutta, Chris Jean Elias, Henry A. Lester, Marie‐Françoise Chesselet · 2018 · Neurobiology of Disease
5. Transcriptional regulation by nicotine in dopaminergic neurons
   Beverley M. Henley, Brian A. Williams, Rahul Srinivasan, Bruce N. Cohen, Cheng Xiao, Elisha D.W. Mackey, Barbara J. Wold, Henry A. Lester · 2013 · Biochemical Pharmacology
6. Nicotine Attenuates Morphological Deficits in a Contusion Model of Spinal Cord Injury
   R. Ravikumar, Isabella Fugaccia, Stephen W. Scheff, James W. Geddes, Cidambi Srinivasan, Michal J. Toborek · 2005 · Journal of Neurotrauma
7. Nicotine-induced FGF-2 mRNA in rat brain is preserved during aging
   Natale Belluardo, Giuseppa Mudò, Mariann Blum, Nobuyuki Itoh, Luigi F. Agnati, Kjell Fuxé · 2004 · Neurobiology of Aging
8. Can nicotine be used medicinally in Parkinson’s disease?
   Claire Thiriez, Gabriel Villafane, Frédérique Grapin, Gilles Fénelon, Philippe Rémy, Pierre Césaro · 2011 · Expert Review of Clinical Pharmacology
9. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson’s Disease and Schizophrenia
   Miguel Pérez de la Mora, Juan C. Hernández-Mondragón, Minerva Crespo‐Ramírez, José del Carmen Rejón-Orantes, Dasiel O. Borroto‐Escuela, Kjell Fuxé · 2019 · Neuroscience
10. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease
    Jung-Eun Park, Soon‐Tae Lee, Wooseok Im, Kon Chu, Manho Kim · 2008 · Neuroscience Letters
11. Crucial roles of the CHRNB3–CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research
    L Wen, Z Yang, Wenyan Cui, M D Li · 2016 · Translational Psychiatry
12. Nicotinic Receptor Modulation for Neuroprotection and Enhancement of Functional Recovery Following Brain Injury or Disease
    James R. Pauly, Christina M. Charriez, Masha Guseva, Stephen W. Scheff · 2004 · Annals of the New York Academy of Sciences
13. Angiotensin II Blocks Nicotine-Mediated Neuroprotection against β-Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1
    Seán Shaw, Merouane Bencherif, Mario B. Marrero · 2003 · Journal of Neuroscience
14. Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease
    Xiomara A. Perez · 2015 · Neuropsychology Review
15. MDMA modifies active avoidance learning and recall in mice
    José Manuel Trigo, Araceli Cabrero-Castel, Fernando Berrendero, Rafael J. Maldonado, Patricia Robledo · 2008 · Psychopharmacology
16. Regulation of Glutamate Release by α7 Nicotinic Receptors: Differential Role in Methamphetamine-Induced Damage to Dopaminergic and Serotonergic Terminals
    Nicole A. Northrop, Laura Proud Smith, Bryan K. Yamamoto, David J. Eyerman · 2010 · Journal of Pharmacology and Experimental Therapeutics
17. Conserved Nicotine-Activated Neuroprotective Pathways Involve Mitochondrial Stress
    J. Brucker Nourse, Gilad Harshefi, Adi Danfi Marom, Abdelrahaman Karmi, Hagit Cohen Ben-Ami, Kim A. Caldwell, Guy A. Caldwell, Millet Treinin · 2020 · iScience
18. “Olfactory three-needle” acupuncture enhances synaptic function in A𝜷1-42-induced Alzheimer’s disease via activating PI3K/AKT/GSK-3𝜷 signaling pathway
    Yuan Wang, Ani Zheng, Huan Yang, Qiang Wang, Bo Xu Ren, Ting Guo, Jing Qiang, Hui Cao, Yujie Gao, Lei Xu et al. · 2021 · Journal of Integrative Neuroscience
19. Emerging preclinical pharmacological targets for Parkinson's disease
    Sandeep Vasant More, Dong‐Kug Choi · 2016 · Oncotarget
20. Inhibitory Effects of Cigarette Smoke on Glial Inducible Nitric Oxide Synthase and Lack of Protective Properties Against Oxidative Neurotoxins In Vitro
    ELIZABETH A. MAZZIO, Malak G. Kolta, Renee Reams, Karam F. A. Soliman · 2004 · NeuroToxicology
21. Proconvulsant-induced seizures in α4 nicotinic acetylcholine receptor subunit knockout mice
    John Y. F. Wong, Shelley A. Ross, Craig D. McColl, Jim S. Massalas, Emma Powney, David Isaac Finkelstein, Malcolm Clark, Malcolm Kenneth Horne, Samuel Frank Berkovic, John Drago · 2002 · Neuropharmacology
22. Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies
    Linda Chang, Huajun Liang, Suresh R. Kandel, Johnny J. He · 2020 · Journal of Neuroimmune Pharmacology
23. lynx1 Supports Neuronal Health in the Mouse Dorsal Striatum During Aging: an Ultrastructural Investigation
    Atsuko Kobayashi, Rell L. Parker, Ashley P. Wright, Hajer Brahem, Pauline Ku, Katherine M. Oliver, Andreas Walz, Henry A. Lester, Julie M. Miwa · 2014 · Journal of Molecular Neuroscience
24. Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice
    María Juliana Orejarena, Fernando Berrendero, Rafael J. Maldonado, Patricia Robledo · 2009 · Psychopharmacology
25. Nicotine Treatment Ameliorates Blood-Brain Barrier Damage After Acute Ischemic Stroke by Regulating Endothelial Scaffolding Protein Pdlim5
    Xiaoyan Hu, Jiali Dong, Panpan Geng, Yanyun Sun, Weihong Du, Xiaoyun Zhao, Qian Wang, Changqing Liu, Xiaona Wang, Yushan Liu et al. · 2023 · Translational Stroke Research
26. Treatment with acetyl-L-carnitine exerts a neuroprotective effect in the sciatic nerve following loose ligation: a functional and microanatomical study
    Lorenzo Di Cesare Mannelli, Daniele Tomassoni, Vincenzo Bramanti, Carla Ghelardini, Francesco Amenta, Alessandra Pacini · 2018 · Neural Regeneration Research
27. Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders
    S. Mitra, Shailesh N. Khatri, Malabika Maulik, A. Bult-Ito, M. Schulte · 2020 · International Journal of Molecular Sciences
28. Literature-Related Discovery (LRD)
    Ronald Neil Kostoff, Joel A. Block, Jeffrey L. Solka, Michael Brandon Briggs, Robert L. Rushenberg, Jesse A. Stump, Dustin Johnson, Terence J. Lyons, Jeffrey R. Wyatt · 2007 · Defense Technical Information Center (DTIC)
29. Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
    Mohamed Bilal Fares, Omar Alijevic, Stéphanie Johne, Cassia Overk, Makoto Hashimoto, Athanasios Kondylis, Anthony Adame, Rémi Dulize, Dariusz Peric, Catherine Nury et al. · 2023 · Frontiers in Neuroscience
30. Neuronal migration is transiently delayed by prenatal exposure to intermittent hypoxia
    Jennifer L. Zechel, Jorge Luis Gamboa, Allyn Peterson, Michelle A. Puchowicz, Warren R. Selman, W. David Lust · 2005 · Birth Defects Research Part B Developmental and Reproductive Toxicology
31. Chronic Nicotine Treatment Increases nAChRs and Microglial Expression in Monkey Substantia Nigra After Nigrostriatal Damage
    Maryka Quik, Carla Campos, Neeraja Parameswaran, J. William Langston, J. Michael McIntosh, Michael Yeluashvili · 2009 · Journal of Molecular Neuroscience
32. Effect of nicotine pretreatment on arsenic-induced oxidative stress in male Wistar rats
    Vidhu Pachauri, Swaran J.S. Flora · 2013 · Human & Experimental Toxicology
33. Training on motor and visual spatial learning tasks in early adulthood produces large changes in dendritic organization of prefrontal cortex and nucleus accumbens in rats given nicotine prenatally
    Arif Muhammad, Richelle Mychasiuk, S. Hosain, Ayuno Nakahashi, C. Carroll, Robbin L. Gibb, Bryan E Kolb · 2013 · Neuroscience
34. Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
    I‐Chi Lai, Alessandra Porcu, Benedetto Romoli, Maria N. Keisler, Fredric P. Manfredsson, Susan B. Powell, Davide Dulcis · 2023 · International Journal of Molecular Sciences
35. Acción de la nicotina como antidepresivo y regulador del sueño en sujetos deprimidos
    Patricia Vieyra-Reyes, Arturo Venebra-Muñoz, Bruno Tonatiuh Rivas-Santiago, Fabio García García · 2009 · Revista de Neurología
36. Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum
    Jessika Urbanavicius, Margot Ferreira, Gustavo Costa, Juan Andrés Abin‐Carriquiry, Susan Wonnacott, Federico Dajas · 2007 · Journal of Neurochemistry
37. Activities of cAMP-dependent protein kinase and protein kinase C are modulated by desensitized nicotinic receptors in the rat brain
    Xiu‐Lan Sun, Yue Liu, Gang Hu, Hai Wang · 2004 · Neuroscience Letters
38. Genetic deficiency of β2-containing nicotinic receptors attenuates brain injury in ischemic stroke
    Q. Liu, Zhiwei Tang, Yan Xiang Gan, Wei Wu, Ariana Kousari, Antonio La Cava, Fu‐Dong Shi · 2013 · Neuroscience
39. Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data
    Hidde Douna, B.M. Bavelaar, H. Pellikaan, Berend Olivier, Toine Pieters · 2012 · The Open Pharmacology Journal
40. Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice
    Jordan M. Buck, Alysse S. Morris, Sydney J. Weber, Jacob Raber, Jessica A. Siegel · 2017 · Behavioural Brain Research
41. Lynx1 and the family of endogenous mammalian neurotoxin-like proteins and their roles in modulating nAChR function
    Talulla B. Palumbo, Julie M. Miwa · 2023 · Pharmacological Research
42. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
    Paula L. Vieira‐Brock, Lisa M. McFadden, Shannon M. Nielsen, Jonathan D. Ellis, Elliot T. Walters, Kristen A. Stout, J. Michael McIntosh, Diana G. Wilkins, Glen R. Hanson, Annette E. Fleckenstein · 2015 · Journal of Pharmacology and Experimental Therapeutics
43. Nicotine Chemistry, Pharmacology, and Pharmacokinetics
    Diana L. McKinney, Andrea Vansickel · 2016 · Elsevier eBooks
44. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit
    Sakari Leino, Sini K. Koski, Raisa Hänninen, Tuukka Tapanainen, Saara Rannanpää, Outi Salminen · 2018 · Neuropharmacology
45. Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study
    Sanaa A.M. Elgayar, Ola A. Hussein, Heba A. Mubarak, Amany M Ismaiel, Asmaa M. S. Gomaa · 2022 · Ultrastructural Pathology
46. Nicotine Exposure Does not Alter Plasma to Brain Choline Transfer
    Paul R. Lockman, Julie A. Gaasch, Ghia McAfee, Thomas J. Abbruscato, Cornelis J. Van der Schyf, David D. Allen · 2006 · Neurochemical Research
47. Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice
    Ainhoa Plaza‐Zabala, Xavier Viñals, Rafael J. Maldonado, Patricia Robledo · 2010 · Psychopharmacology
48. Effect of varenicline on behavioral deficits in a rat model of Parkinson’s disease induced by unilateral 6-hydroxydopamine lesion of substantia nigra
    Ruyal F. Tan, Funda F. Bölükbaşı Hatip, Öznur Açikalin, Atsushi Yamauchi, Yasufumi Kataoka, Izzettin Hatip‐Al‐Khatib · 2017 · Behavioural Pharmacology
49. Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy
    Jackson Fink, Heather Pathak, John M. Smith, Cindy Achat‐Mendes, Robert L. Haining · 2019 · Biomolecules
50. Central Cholinergic Synapse Formation in Optimized Primary Septal-Hippocampal Co-cultures
    Sarra Djemil, Claire R. Ressel, Mai Abdel‐Ghani, Amanda K. Schneeweis, Daniel T.S. Pak · 2020 · Cellular and Molecular Neurobiology
51. Drugs of anesthesia, central nicotinic receptors and Parkinson's disease
    Vincenzo Fodale, C Praticò, L. B. Santamaria · 2004 · Parkinsonism & Related Disorders
52. Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
    A. Ribeiro-Carvalho, P.H. Leal-Rocha, J. Isnardo-Fernandes, U.C. Araújo, Y. Abreu-Villaça, C.C. Filgueiras, A.C. Manhães · 2021 · Brazilian Journal of Medical and Biological Research
53. The protective role of cigarette smoking against Parkinson’s disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms
    Quanquan Gu, Xiaocao Liu, Qingze Zeng, Xiaojun Guan, Cheng Zhou, Tao Guo, Baorong Zhang, Minming Zhang · 2022 · Quantitative Imaging in Medicine and Surgery
54. Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease
    Namrata Kumari, LD Cooke, Abby L. Olsen · 2025 · Journal of Parkinson s Disease
55. Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
    Anderson Ribeiro‐Carvalho, Pedro Henrique Leal-Rocha, Jemima Isnardo-Fernandes, Ulisses César Araújo, Yael Abreu‐Villaça, Cláudio Carneiro Filgueiras, Alex C. Manhães · 2021 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
56. Evidence for Sequence-Dependent and Reversible Nonspecific Effects of PS-Capped Antisense Treatment After Intracerebral Administration
    Sandra M. Boye, Amynah A. A. Pradhan, Rebecca J. Grant, Paul B. S. Clarke · 2002 · Antisense and Nucleic Acid Drug Development
57. The Reassessed Impact of Nicotine against Neurotoxicity in Mesencephalic Dopaminergic Cell Cultures and Neuroblastoma N18TG2 Cells
    Marcin Delijewski, Khaled Radad, Christopher Krewenka, Barbara Kranner, Rudolf Moldzio · 2021 · Planta Medica
58. Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors
    Michelle G. Baladi, Shannon M. Nielsen, J. Michael McIntosh, Glen R. Hanson, Annette E. Fleckenstein · 2016 · Behavioural Pharmacology
59. Alkaloids
    Christophe Wiart · 2014 · Elsevier eBooks
60. In silico analysis of nicotine’s molecular targets in Parkinson’s disease
    Hai Duc Nguyen · 2025 · Xenobiotica
61. Nicotine Attenuates Pathogenesis of Parkinson’s Disease via α7-nAChR-Mediated Lipid Metabolic Reprogramming and Anti-inflammatory Signaling
    Jingjing Yang, Yingyan Li, Hongjuan Wang, Xin Li, Huan Chen, Hongwei Hou, Qingyuan Hu · 2025 · Molecular Neurobiology
62. Assessment of Cypermethrin Residues in Tobacco by a Bioelectric Recognition Assay (BERA) Neuroblastoma Cell-Based Biosensor
    Theofylaktos Apostolou, Sophie Mavrikou, Nikoleta-Kleio Denaxa, Georgia Paivana, Peter Anargyrou Roussos, Spyridon E. Kintzios · 2019 · Chemosensors
63. Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model
    Ilya D. Ionov, Irina I. Pushinskaya, Nicholas P. Gorev, Larissa A. Shpilevaya · 2019 · Psychopharmacology
64. Pharmacological strategies for Parkinson’s disease
    José-Rubén García-Montes, Alejandra Boronat-García, René Drucker-Colı́n · 2012 · Health
65. Neurochemistry of Nigral Degeneration
    Jayaraman Rao · 2003 · CRC Press eBooks
66. Investigation of Inhibition Effect of Nicotine and Dopamine on Alpha-synuclein
    Hakan Alıcı · 2021 · Journal of Computational Biophysics and Chemistry
67. Contribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence
    Ming D. Li · 2018 · Springer eBooks
68. Nicotine impact on rat substantia nigra compacta
    Sanaa A.M. Elgayar, Ola A. Hussein, Heba A. Mubarak, Amany M Ismaiel, Asmaa M. S. Gomaa · 2021 · Anatomy & Cell Biology
69. Case-only study of interactions between specific genetic polymorphisms and cigarette smoking in the aetiology of Parkinson's disease
    Yifu Deng · 2005 · Centre for Health Research; Faculty of Health; Institute of Health and Biomedical Innovation
70. A Role for Neuronal Nicotinic Acetylcholine Receptors in Dopamine-Mediated Behaviors and the Hypnotic Response to Anesthetics: A Dissertation
    Lindsey G. Soll · 2013 · eScholarship@UMassChan
71. Role of Trichloroethylene in Parkinson’s Disease
    Samuel M. Goldman, Stephanie Whisnant Cash · 2014 · Molecular and integrative toxicology
72. The Effects of Nicotine Treatment on Striatal Dopamine Neurotransmission after Traumatic Brain Injury
    Samuel S. Shin · 2011 · D-Scholarship@Pitt (University of Pittsburgh)
73. MRI assessment of brain iron content in methamphetamine users
    Yosef A. Berlow · 2014
74. Genetic regulation of endoplasmic reticulum chaperones and pro-inflammatory cytokines by neuronal alpha4beta2 nicotinic receptors
    Vishnu Hosur · 2010
75. Nicotine Prevents MPTP-induced Dopaminergic Neurodegeneration
    Jong‐Min Kim, Jeong Ja O, Beom Seok Jeon · 2008 · Experimental Neurobiology
76. Brief Communication Evidence for Sequence-Dependent and Reversible Nonspecific Effects of PS-Capped Antisense Treatment After Intracerebral Administration
    Sandra M. Boye, Rebecca Grant, Paul B. S. Clarke · 2002
77. A Role for Nicotine in Neuroprotection Against Disorders Associated With Monoaminergic and Cognitive Dysfunction
    de Lima Vieira Brock, Paula · 2019 · J. Willard Marriott Library
78. Early Nicotine Exposure Is Protective in Familial and Idiopathic Models of Parkinson’s Disease
    Lori M. Buhlman, Jun Hu · 2016 · Springer eBooks
79. Perinatal asphyxia and intervention: possible neuroprotective effects of intravenous nicotine administration. An experimental study in newborn piglets
    Jannicke Hanne Andresen · 2008
80. Corticohippocampal Neuroenergetics and histomorphology in aluminium-induced neurotoxicity: Putative therapeutic roles of ascorbic acid and nicotine
    Ismail Gbadamosi, Gabriel Olaiya Omotoso · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
81. Disease associations—Alzheimer’s disease, schizophrenia, Parkinson’s disease, autism, and cancer
    R. Thomas Boyd · 2023 · Elsevier eBooks
82. A network-based pharmacological study of the network mechanism of Rhizoma Gastrodiae for Parkinson’s disease
    Lei Wan · 2024 · New discovery.
83. Associations Between Nicotine Metabolites and Serum Neurofilament Light Chain Levels in the General Population
    Qianqian Ji, Erhan Tang, Yueting Liao, Jialei Yang, Yunzhang Wang, Yiqiang Zhan · 2025 · Chronic Diseases and Translational Medicine
84. Vulnérabilité des neurones dopaminergiques dans la maladie de Parkinson : rôle des afférences excitatrices des systèmes cholinergique pédonculopontin et orexinergique hypothalamique
    Manale Bensaid · 2014 · theses.fr (ABES)
85. Evaluation of the Dopaminergic System Using In Vivo PET Imaging and Post-Mortem Analyses in the Context of Mild Neurodegenerative and Neuroinflammatory PD Models
    Pauline Roost · 2020 · theses.fr (ABES)
86. PNU-120596, an α7 nicotinic acetylcholine receptor positive allosteric modulator, attenuates microglial activation and protects dopaminergic neurons from inflammatory injury independently of canonical α7 nicotinic acetylcholine receptor signaling
    Yasuhiko Izumi, Kenta Niwa, Yuichi Kamei, Akinori Akaike, Yutaka Kōyama, Toshiaki Kume · 2026 · European Journal of Pharmacology
87. The contribution of genetically manipulated animals to the study of stimulant and alcohol addiction
    David Stephens, Andy N. Mead, Tamzin L. Ripley · 2003 · Cambridge University Press eBooks